Bronchonib 150mg Capsule is a targeted therapy medication used in the treatment of certain types of non-small cell lung cancer (NSCLC). The active ingredient, Nintedanib, is a tyrosine kinase inhibitor that works by blocking the activity of specific enzymes involved in cancer cell growth and blood vessel formation that feeds the tumor. By inhibiting these pathways, Bronchonib helps to slow down or stop the progression of lung cancer.
Bronchonib 150mg Capsule is indicated for patients with advanced or metastatic non-small cell lung cancer whose disease has progressed after initial chemotherapy. It is typically prescribed as a second-line treatment option.
The usual dosage of Bronchonib 150mg Capsule is 150mg taken orally twice daily. It is important to take the capsules at the same time each day, with or without food. Do not crush or chew the capsules; swallow them whole with water. If a dose is missed, take it as soon as remembered, unless it is close to the time for the next dose.
Common side effects may include diarrhea, nausea, vomiting, abdominal pain, and elevated liver enzymes. Serious side effects can occur, so it is crucial to inform your doctor immediately about any new or worsening symptoms. Bronchonib should be stored at room temperature, away from moisture and heat, and out of reach of children.
